.png)
AstraZeneca announced a $15 billion investment in China through 2030 to expand R&D, manufacturing, and advanced therapies, strengthening China-UK healthcare collaboration and delivering next-generation treatments worldwide.
The new wave of Nipah virus in India has once again placed the pharma industry in the limelight and why their involvement is more important than ever. In West Bengal, authorities confirmed two Nipah cases since December 2025, with extensive...
Lupin Limited has earned the highest ‘A’ leadership rating from CDP for climate change and water security, reinforcing its position among global sustainability leaders in the pharmaceutical industry.
Bayer and Vanderbilt University Medical Center (VUMC) have entered a five-year collaboration to accelerate the development of new therapies for cardiovascular and kidney diseases, combining expertise in drug discovery and clinical research.
Eli Lilly has received FDA Breakthrough Therapy designation for sofetabart mipitecan, a novel antibody-drug conjugate showing early promise for patients with platinum-resistant ovarian cancer.
Sterling Hospitals, Ahmedabad, successfully performed a complex Robotic Whipple surgery, offering new hope in pancreatic cancer treatment with minimal invasiveness and faster recovery.
Novo Nordisk expands its diabetes cell therapy partnership with Aspect Biosystems, aiming to develop implantable insulin-producing cells and advance next-generation treatments for type 1 diabetes patients.
Syngene International has extended its strategic research collaboration with Bristol Myers Squibb through 2035, expanding integrated services across discovery, development, manufacturing, and clinical programs.
AbbVie today reported positive topline results from its Phase 3 EPCORE DLBCL-1 trial, showing epcoritamab improved progression-free survival in adults with relapsed or refractory diffuse large B-cell lymphoma.
Entod Pharmaceuticals has developed the world's first losartan eye drops to treat corneal scarring, a major cause of vision loss. The innovation marks a global milestone in ophthalmic drug formulation.
, CDSCO.jpg)